Pancreatic Cell News Volume 13.27 | Jul 12 2022

    0
    51








    2022-07-12 | PACN 13.27


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 13.27 – 12 July, 2022
    TOP STORY

    TET1 Dioxygenase Is Required for FOXA2-Associated Chromatin Remodeling in Pancreatic Beta-Cell Differentiation

    The authors used a human embryonic stem cell differentiation system, in which TET1/TET2/TET3 triple knockout cells displayed severe defects in pancreatic β-cell specification.
    [Nature Communications]

    Full Article

    ON1104SM-Small-Molecules-Wallchart-728x90
    PUBLICATIONSRanked by the impact factor of the journal

    Small RNAs Derived from tRNA Fragmentation Regulate the Functional Maturation of Neonatal β Cells

    Scientists identified three tRNA-derived fragments abundant in neonatal rat islets originating from 5′ halves of histidine and glutamate tRNAs. Their inhibition in these islets reduced β cell proliferation and insulin secretion.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Single-Nucleus RNA-Sequencing Reveals Singular Gene Signatures of Human Ductal Cells during Adaptation to Insulin Resistance

    Investigators indicated that subsets of ductal cells were able to gain β-cell identity and reflected a form of compensation during the adaptation to insulin resistance in both physiological and pathological states.
    [JCI Insight]

    AbstractFull Article

    Mitoribosome Insufficiency in β Cells Is Associated with Type 2 Diabetes-Like Islet Failure

    Researchers investigated the effects of the mitoribosomal gene on β-cell function and glucose homeostasis and found deregulation of most mitoribosomal genes in islets from individuals with type 2 diabetes, including partial downregulation of CRIF1.
    [Experimental & Molecular Medicine]

    Full Article

    Pharmacological Targeting of TFIIH Suppresses KRAS Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL

    By integrating genomic analysis with an arrayed RNAi druggable genome screen and drug profiling of a KRAS/TP53 mutant PDAC cell line derived from a patient-derived xenograft, scientists identified numerous targetable vulnerabilities that revealed both known and novel functional aspects of pancreatic cancer biology.
    [Cancer Research]

    Abstract

    ATG7 Is a Haploinsufficient Repressor of Tumor Progression and Promoter of Metastasis

    The authors reported the effects of deleting the essential autophagy gene Atg7 in a model of PDAC, in which mutant KrasG12D and mutant Trp53172H were induced in adult tissue leading to metastatic PDAC.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    cGAS-STING Signaling Encourages Immune Cell Overcoming of Fibroblast Barricades in Pancreatic Cancer

    Researchers investigated the impact of cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) expression and the presence of cancer-associated fibroblasts upon immune cell infiltration in PDACs.
    [Scientific Reports]

    Full Article

    Lipocalin-2 Inhibits Pancreatic Cancer Stemness via the AKT/C-Jun Pathway

    Immunohistochemistry results of tumor tissue chips together with gene expression omnibus sequencing files confirmed that lipocalin-2 was highly expressed in pancreatic carcinoma compared with that in normal tissues.
    [Human Cell]

    Full Article

    PKCι Is a Promising Prognosis Biomarker and Therapeutic Target for Pancreatic Cancer

    To understand the pattern of protein kinase C (PKC) enzymes in PDAC, investigators examined all PKC family member genes expression in PDAC and matched normal tissues.
    [Pathobiology]

    Full Article

    Microscopy images of pluripotent stem cells (PSCs) and PSC-derived cells for the #StemCellfie contest.
    REVIEWS

    Extracellular Vesicles in β Cell Biology: Role of Lipids in Vesicle Biogenesis, Cargo, and Intercellular Signaling

    Scientists review the implications of extracellular vesicle (EV) release from β cells for type 1 diabetes (T1D) pathogenesis, how EVs and their cargo might be leveraged as biomarkers of this process, and how EVs might be engineered as a therapeutic candidate to counter T1D outcomes.
    [Molecular Metabolism]

    Full Article

    β Cell Replacement Therapy for the Cure of Diabetes

    Investigators discuss recent updates on islet transplantation to overcome donor shortage and immunosuppressant-related complications and share their perspectives on future β cell replacement therapy.
    [Journal of Diabetes investigation]

    AbstractFull Article

    Perspectives and Challenges on the Potential Use of Exosomes in Bioartificial Pancreas Engineering

    The authors discuss the potential role that exosomes and their specific biofactors may play to improve and sustain the function of this bioartificial construct.
    [Annals of Biomedical Engineering]

    Abstract

    INDUSTRY AND POLICY NEWS

    Inventiva Announces the Screening of the First Patient in LEGEND, a Phase IIa Combination Trial with Lanifibranor and Empagliflozin in Patients with NASH and T2D

    Inventiva announced the screening in the US of the first patient in its LEGEND Phase IIa combination trial with lanifibranor and empagliflozin in patients with non-alcoholic steatohepatitis (NASH) and type 2 diabetes (T2D).
    [Inventiva]

    Press Release

    Vertex Absorbs ViaCyte and Its Stem Cell-Based Diabetes Treatment for $320M, Clearing Out Competition

    Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from an FDA clinical hold, the company is clearing out potential competition by buying ViaCyte for $320 million.
    [Fierce Biotech]

    Press Release

    FEATURED EVENT

    5th International Cancer Symposium

    November 2 – 4, 2022
    Lyon, France

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Cancer Research

    Albert Einstein College of Medicine – Bronx, New York, United States

    Associate Professor – Thematic Research Programs

    The Chinese University of Hong Kong – Hong Kong, China

    Associate Professor – Cardiovascular Research

    The University of Tennessee Health Science Center – Memphis, Tennessee, United States

    Postdoctoral Fellow – Leukemia and Pancreatic Cancer Research

    University Health Network – Toronto, Ontario, Canada

    Professor – Experimental Diabetes Research

    Uppsala University – Uppsala, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter